Article Text

other Versions

PDF
Iritis, glaucoma and corneal decompensation associated with BrightOcular cosmetic iris implant
  1. Ahmad M Mansour1,2,
  2. Iqbal Ike K Ahmed3,
  3. Brennan Eadie3,
  4. Elias Chelala4,
  5. Joanna S Saade1,
  6. Stephen G Slade5,
  7. Ali A Mearza6,
  8. Dipak Parmar7,
  9. Marwan Ghabra7,
  10. Sheila Luk8,
  11. Alla Kelly9,
  12. Stephen C Kaufman9,10
  1. 1Department of Ophthalmology, American University of Beirut, Beirut, Lebanon
  2. 2Department of Ophthalmology, Rafic Hariri University Hospital, Beirut, Lebanon
  3. 3Department of Ophthalmology, University of Toronto, Toronto, Ontario, Canada
  4. 4Department of Ophthalmology, Hotel Dieu de France, Beirut, Lebanon
  5. 5The Laser Center, Houston, Texas, USA
  6. 6Department of Ophthalmology, Imperial College, London, UK
  7. 7Department of Ophthalmology, Whipps Cross University Hospital, London, UK
  8. 8Department of Ophthalmology, Western Eye Hospital, London, UK
  9. 9Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USA
  10. 10Department of Ophthalmology, State University of New York Downstate, Brooklyn, New York, USA
  1. Correspondence to Iqbal Ike K Ahmed, Department of Ophthalmology, University of Toronto, Toronto, Ontario, Canada; ikeahmed{at}mac.com

Abstract

Purpose NewColorIris cosmetic iris implants have a record of high ocular morbidity and are no longer in use. Newer generation of iris implants, BrightOcular, have patented posterior grooves in order to decrease iris touch and facilitate aqueous flow around the implant. However, little is known about their safety despite their implantations in 10 countries.

Methods Collaborative case series of patients who had bilateral implantation of cosmetic iris implants solely for cosmetic reasons.

Results 12 cases were collected being distributed as Caucasian (10) and Asian (2), women (11) and man (1) and with a mean age of 32 years. Ocular manifestations were present in 11 subjects and included anterior uveitis (10 of 12; 83.3%), glaucoma (7 of 12; 58.3%) and corneal decompensation (6 of 12; 50%). Visual acuity was normal in seven, decreased in five with two having visual recovery following explantation of the implant. Glaucoma could not be controlled medically in two patients.

Conclusions Cosmetic iris implants carry the risk of ocular damage when implanted in the anterior chamber of normal phakic eyes.

  • Angle
  • Anterior chamber
  • Cornea
  • Cosmesis
  • Glaucoma

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Keith Barton James Chodosh Jost Jonas